Approvals/TGA/ACTILYSE alteplase (rch) 20mg powder for injection, vial with diluent vial

Approved

STANDARD

ACTILYSE alteplase (rch) 20mg powder for injection, vial with diluent vial

Boehringer Ingelheim Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 097231c62e67f2b9
Product Name: ACTILYSE alteplase (rch) 20mg powder for injection, vial with diluent vial
Artg Id: 43375
Artg Name: ACTILYSE alteplase (rch) 20 mg powder for injection vial with diluent vial
Sponsor: Boehringer Ingelheim Pty Ltd
Company Detail Path: /organization/boehringer-ingelheim-pty-ltd
Artg Date: 1993-05-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/a76086df442d92b70b55c1dd33bea61c.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

097231c62e67f2b9

Type

Standard